← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Camino Pharma, Llc
San Diego, CA
$2,888,160
Total funding
2
Grants
Funding over time
peak $994.9K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,888,160 · 2
By mechanism
U43$1,968,844 · 1
R43$919,316 · 1
Investigators at Camino Pharma, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Preclinical validation of mGlu2 PAMs in alcohol use disorder$994,906
U43 · FY2024 · AA
Preclinical validation of mGlu2 PAMs in alcohol use disorder$973,938
U43 · FY2023 · AA
Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptors 2 & 3 (mGlu2/3) for the Treatment of Depression$469,863
R43 · FY2020 · MH
Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptors 2 & 3 (mGlu2/3) for the Treatment of Depression$449,453
R43 · FY2021 · MH